DR. ROBERT M SENIOR, MD
Osteopathic Medicine at Parkview Pl, Saint Louis, MO

License number

Missouri R2614

Personal information

See more information about ROBERT M SENIOR at radaris.com

Name

Address

Phone

Robert M Senior, age 87

24 Aberdeen Ave, Saint Louis, MO 63105

(314) 727-8786

Robert M. Senior

Saint Louis, MO

(314) 727-8786

Professional information

See more information about ROBERT M SENIOR at trustoria.com

Dr. Robert M Senior, Saint Louis MO - MD (Doctor of Medicine)

Specialties:

Pulmonology

Address:

Lung & Asthma Center
4921 Parkview Pl SUITE B, Saint Louis 63110
(314) 454-8917 (Phone)

Certifications:

Internal Medicine, 1968, Pulmonary Disease, 1969

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
George Washington University / School of Medicine And Health Sciences
Graduated: 1961
Barnes-Jewish Hospital
St Louis Jewish Hosp
Colum P&S

Robert Morris Senior, Saint Louis MO

Specialties:

Internal Medicine, Pulmonary Disease, Family Medicine

Work:

Washington University at St. Louis
4921 Parkview Pl, Saint Louis, MO 63110 Barnes Jewish Hospital
216 S Kingshighway Blvd, Saint Louis, MO 63110 Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110

Education:

George Washington University (1961)

Stimulation Of Chemotaxis By Chemotactic Peptides

US Patent:

4605413, Aug 12, 1986

Filed:

Sep 19, 1983

Appl. No.:

6/533670

Inventors:

Dan W. Urry - Birmingham AL
Robert M. Senior - Clayton MO

Assignee:

The University of Alabama at Birmingham - Birmingham AL

International Classification:

A61F 202, A01N 102, A01N 2500, A61K 938

US Classification:

623 11

Abstract:

A method of stimulating chemotaxis toward a prosthetic device is disclosed, which method comprises incorporating a chemotactic peptide of the formula B. sup. 1 -X-(APGVGV). sub. n -Y-B. sup. 2 wherein A is a peptide-forming residue of L-alanine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; B. sup. 1 is H or a biocompatible N-terminal group; B. sup. 2 is OH, OB. sup. 3 where B. sup. 3 is a non-toxic metal ion, or a biocompatible C-terminal group; X is PGVGV, GVGV, VGV, GV, V, or a covalent bond; Y is APGVG, APGV, APG, AP, A, or a covalent bond; and n is an integer from 1 to 100; into a surface of the prosthetic device. Prosthetic devices which have the property of enhancing invasion of elastic fiber synthesizing fibroblasts as a result of the chemotactic peptide are also disclosed.